Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Hot Topics in AML from the Virtual 2020 Lymphoma, Leukemia and Myeloma Congress
Videos
Hot Topics in AML from the Virtual 2020 Lymphoma, Leukemia and Myeloma Congress
10/24/2020
Gail J. Roboz, MD, summarizes the sessions she presented and debates she took part in at this year's congress.
Gail J. Roboz, MD, summarizes the sessions she presented and debates she took part in at this year's congress.
Gail J. Roboz, MD, summarizes...
10/24/2020
Oncology
James Bussel, MD, Shares Highlights from the Pre-LLM Congress Non-Malignant Day
Videos
James Bussel, MD, Shares Highlights from the Pre-LLM Congress Non-Malignant Day
10/20/2020
Dr Bussel shares insight on hot topics, highlights, and key takeaways from this year's virtual event.
Dr Bussel shares insight on hot topics, highlights, and key takeaways from this year's virtual event.
Dr Bussel shares insight on hot...
10/20/2020
Oncology
Efficacy and Safety of Current Treatment Options for HCL
Videos
Efficacy and Safety of Current Treatment Options for HCL
01/20/2020
Jacqueline Barrientos, MD, MS, discusses how the treatment landscape for hairy cell leukemia has evolved.
Jacqueline Barrientos, MD, MS, discusses how the treatment landscape for hairy cell leukemia has evolved.
Jacqueline Barrientos, MD, MS,...
01/20/2020
Oncology
Differences in Biology and Treatment of FL and MZL
Videos
Differences in Biology and Treatment of FL and MZL
01/20/2020
Thomas Habermann, MD, explains differences in the treatment approaches for follicular and marginal zone lymphomas.
Thomas Habermann, MD, explains differences in the treatment approaches for follicular and marginal zone lymphomas.
Thomas Habermann, MD, explains...
01/20/2020
Oncology
Updates in Diagnosing and Treating Peripheral T-Cell Lymphoma
Videos
Updates in Diagnosing and Treating Peripheral T-Cell Lymphoma
01/17/2020
Jia Ruan, MD, PhD, Weill Cornell Medicine, shares updates on the diagnosis and treatment of peripheral T-cell lymphoma.
Jia Ruan, MD, PhD, Weill Cornell Medicine, shares updates on the diagnosis and treatment of peripheral T-cell lymphoma.
Jia Ruan, MD, PhD, Weill Cornell...
01/17/2020
Oncology
Ibrutinib Plus Rituximab Yields Significant PFS Benefit Over FCR for CLL
Videos
Ibrutinib Plus Rituximab Yields Significant PFS Benefit Over FCR for CLL
01/12/2020
Neil Kay, MD, discusses results from the E1912 trial, which showed a significant PFS benefit with ibrutinib plus rituximab over standard FCR in CLL.
Neil Kay, MD, discusses results from the E1912 trial, which showed a significant PFS benefit with ibrutinib plus rituximab over standard FCR in CLL.
Neil Kay, MD, discusses results...
01/12/2020
Oncology
The Role of Observation in Follicular Lymphoma
Videos
The Role of Observation in Follicular Lymphoma
01/06/2020
Carla Casulo, MD, University of Rochester Medical Center, discusses the role of observation in the treatment landscape of follicular lymphoma.
Carla Casulo, MD, University of Rochester Medical Center, discusses the role of observation in the treatment landscape of follicular lymphoma.
Carla Casulo, MD, University of...
01/06/2020
Oncology
Deep Sequencing Impacts Treatment Landscape for MM
Videos
Deep Sequencing Impacts Treatment Landscape for MM
01/03/2020
Gareth Morgan, MD, PhD, discusses deep sequencing and how it is improving the treatment landscape for MM.
Gareth Morgan, MD, PhD, discusses deep sequencing and how it is improving the treatment landscape for MM.
Gareth Morgan, MD, PhD,...
01/03/2020
Oncology
Treatment Options for Advanced Stage Lymphoma
Videos
Treatment Options for Advanced Stage Lymphoma
01/03/2020
Joseph Connors, MD, discusses the best choices for treating patients with advanced stage lymphoma.
Joseph Connors, MD, discusses the best choices for treating patients with advanced stage lymphoma.
Joseph Connors, MD, discusses...
01/03/2020
Oncology
Videos
Should You Stop TKI Treatment for CML in Major Molecular Response?
12/23/2019
Sangmin Lee, MD, discusses whether or not you should stop TKI treatment in patients with CML in major molecular response.
Sangmin Lee, MD, discusses whether or not you should stop TKI treatment in patients with CML in major molecular response.
Sangmin Lee, MD, discusses...
12/23/2019
Oncology

Advertisement

About

For nearly 2 decades, the Lymphoma, Leukemia & Myeloma Congress (formerly the Lymphoma & Myeloma Congress) has been recognized around the world as the most respected forum for industry-leading hematologic research.

It’s where interdisciplinary specialists convene to explore the controversial and the complex, the emerging and the exciting, and discuss, debate, and discover along the way.

This program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use